Inger Olesen

466 total citations
9 papers, 125 citations indexed

About

Inger Olesen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Inger Olesen has authored 9 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Inger Olesen's work include Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). Inger Olesen is often cited by papers focused on Breast Cancer Treatment Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). Inger Olesen collaborates with scholars based in Australia, United States and Denmark. Inger Olesen's co-authors include Georgina Luscombe, Catherine Boyd, Suzanne Abraham, Gregory M. Peterson, Ray M. Lowenthal, Madhur D. Shastri, Rahul P. Patel, J. Helen Fitton, David M. Ashley and Jackson Thomas and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Eating Disorders and SpringerPlus.

In The Last Decade

Inger Olesen

9 papers receiving 123 citations

Peers

Inger Olesen

PHEOH

ONCOL

PHARM

Titin Andri Wihastuti Indonesia

Weimin Yang China

Sônia Maria Rolim Rosa Lima Brazil

Luciana Oquendo Pereira Brazil

Rodrigo Nunes Lamounier Brazil

Renata C. Gonçalves Brazil

Desmawati Desmawati Indonesia

Giuseppina Della Corte Italy

M. Adler Germany

Shatha Hammad Jordan

Titin Andri Wihastuti Indonesia

Inger Olesen

5 ×0.1

12 ×0.4

PHEOH

6 ×0.3

ONCOL

6 ×0.4

PHARM

10 ×0.8

Citations per year, relative to Inger Olesen Inger Olesen (= 1×) peers Titin Andri Wihastuti

Countries citing papers authored by Inger Olesen

Since Specialization

Citations

This map shows the geographic impact of Inger Olesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Olesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Olesen more than expected).

Fields of papers citing papers by Inger Olesen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Olesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Olesen. The network helps show where Inger Olesen may publish in the future.

Co-authorship network of co-authors of Inger Olesen

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Olesen. A scholar is included among the top collaborators of Inger Olesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Olesen. Inger Olesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Billah, Baki, Md Nazmul Karim, Phillip Antippa, et al.. (2024). Stage-Specific Guideline Concordant Treatment Impacts on Survival in Nonsmall Cell Lung Cancer: A Novel Quality Indicator. Clinical Lung Cancer. 25(8). e466–e478. 2 indexed citations

Geisler, Peter, Marit E. Jørgensen, Christina Viskum Lytken Larsen, et al.. (2024). Lung function measurements in the Greenlandic Inuit population: results from the Greenlandic health survey 2017–2019. European Clinical Respiratory Journal. 11(1). 1 indexed citations

Peterson, Gregory M., et al.. (2018). Monoclonal antibody therapy in cancer: When two is better (and considerably more expensive) than one. Journal of Clinical Pharmacy and Therapeutics. 43(6). 925–930. 6 indexed citations

Lowenthal, Ray M., Gregory M. Peterson, Rahul P. Patel, et al.. (2016). The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer. Integrative Cancer Therapies. 17(1). 99–105. 52 indexed citations

Khasraw, Mustafa, Violet Mukaro, Anne Woollett, et al.. (2015). Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC).. Journal of Clinical Oncology. 33(15_suppl). e12025–e12025. 1 indexed citations

Khasraw, Mustafa, Wei Duan, Violet Mukaro, et al.. (2014). Tailored neoadjuvant epirubicin and cyclophosphamide and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer.. Journal of Clinical Oncology. 32(15_suppl). TPS1135–TPS1135. 2 indexed citations

Banks, Patricia, et al.. (2014). Characteristics of cancer diagnoses and staging in South Western Victoria: A rural perspective. Australian Journal of Rural Health. 22(5). 257–263. 9 indexed citations

Vardy, Janette L., Haryana M. Dhillon, Stephen Clarke, et al.. (2013). Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. SpringerPlus. 2(1). 126–126. 14 indexed citations

Abraham, Suzanne, Georgina Luscombe, Catherine Boyd, & Inger Olesen. (2004). Predictors of the accuracy of self‐reported height and weight in adolescent female school students. International Journal of Eating Disorders. 36(1). 76–82. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact